Eli Lilly secures exclusive rights to Insilico Medicine's AI-discovered oral therapeutics in a deal up to $2.75 billion. This accelerates the path to patient care for challenging diseases. 🎧 Watch the full episode of What the AI?! YouTube, Spotify, Apple Podcasts → https://www.whattheai.fm #AIDrugDiscovery #EliLilly #InsilicoMedicine #Biotech #PharmaInnovation
Search
AI Drug Discovery Breakthrough: Eli Lilly's $2.75B Deal #shorts
Listen On
Recent Episodes
- Is Sam Altman a Liability? The Shocking Testimony
- Elon on the Stand: What the OpenAI Trial Reveals
- Laundry Robots & Frontier Models: Is the Hype Finally Over?
- Your AI Now Has Your Bank Data: The Perplexity x Plaid Move
- Too Dangerous to Release? Anthropic’s Mythos & The Identity Crisis
- The Management Kill-Switch: Why AI Adoption is Surging (But Trust is Tanking)
- There’s a Robot in the White House (And Soon in Yours)
- Side Quests are Over: OpenAI’s "Code Red" Pivot
- Amazon’s AI Broke the Store: 6.3 Million Orders Lost
- See all →